Topics

ChoiceCancerCare.com

Ways Cancer Patients Can Cope with Anxiety Due to Covid-19

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

A cancer diagnosis can be overwhelming to take in, and now with the onset of Coronavirus, cancer patients are growing more anxious and insecure. Having cancer makes you vulnerable to Covid-19. Cancer that affects the body’s immune system like lymphoma or leukemia and treatments such as chemotherapy can weaken your immune system and reduce your ability to fight infections.

 

As a cancer patient anxious about Covid-19, you can do the following to cope with your situation:

 

• Discuss with your health care team– Your cancer care team understands your health better as well as your treatment schedule. Talk to them to weigh your options, and if you have to minimize movement and avoid exposure, telehealth appointments can be arranged. They’ll find ways to be there whenever you’re anxious, depressed, or overwhelmed.

 

• Stay informed without stressing yourself out – A lot of information on Covid-19 is available, both in the media and online. However, you shouldn’t overwhelm yourself with too much information. Just focus on the facts, and follow your doctors’ advice to stay safe.

 

• Always stay in touch– In times like this, you need to keep in touch with people closest to you. Interact with your family and friends regularly to keep your mind off stressing matters regarding your health. Call or chat with them, and you’ll find your stress levels dropping.

 

• Create a schedule and stick to it– Develop a routine with set times for meals, some exercise, sleep, and relaxation to keep you healthy, both emotionally and physically. Watch a movie, walk your pet, do some gardening, or preoccupy yourself with something that you love. Staying active can help you ward off depression and respond better to your cancer treatment.

 

When battling cancer, you should remember to keep calm, talk to your loved ones when you feel lonely, and seek advice from people who can support you. You can also get busy with things that interest you and avoid movement to prevent infection from Coronavirus.

 

 

How Cancer Patients Can Maintain Food Safety

 

During this Coronavirus outbreak, cancer patients need to eat well to boost their immune system. A well-balanced diet high in nutrients is required to help the immune system fight off viruses and bacteria.

 

If, by chance you get infected, your strong immune system can help minimize the severity of the symptoms. In this way, you’ll maintain your strength and allow treatments like immunotherapy to work well.

 

A diet rich in fresh veggies and fruits as well as dairy products is ideal. In situations when trips to the grocery store are limited, you have to find better ways to get fresh, healthy food and keep it safe from germs and bacteria.

 

Here are tips for making sure your food is well cleaned and stored;

 

• Clean your kitchen surfaces– To prevent any food-related illnesses, you should clean and sanitize your kitchen surfaces. Use a bleach solution to wipe all the surface areas you use in preparing food, including your kitchen sink. This will kill all the bacteria and any other foodborne pathogens.

 

• Wash your fruits and veggies– Before storing your fruits and vegetables in the refrigerator, wash them thoroughly with water and rinse in a mixture of water and vinegar. Use a paper towel to dry them. Put dry paper towels in the storage containers to help absorb the gases and moisture released when they ripen. This will also make them last longer in the fridge.

 

• Always make sure you have enough dairy products or their alternatives. Freeze your milk and cheeses to extend their lives.

 

• To minimize your risk of infection, make sure you wash your hands before and after handling food and its packaging. Keep high-risk foods separated from the rest to avoid cross-contamination. Make sure the surfaces exposed to these foods, including cutting boards, containers, and trays, are well sanitized.

 

Knowing what to do and being vigilant with what you consume can keep you safe from illnesses and infections. Try to understand which foods are safe and nutritious will keep you healthy and minimize your risk of any infections.

 

 

 

5 Things that Can Help Reduce Your Cancer Risk

 

Although cancer is unpredictable, you can protect yourself from the risks of the disease. Adopting a healthy lifestyle is the key to lowering your overall risk of cancer. Many factors contribute to the risk of developing cancer, but there are things you can do to prevent the disease.

 

Making the changes below steps below can help you prevent cancer from occurring;

 

• Maintain a healthy weight– You should keep your weight in check to prevent obesity, a risk factor for cancer. Obesity causes chronic inflammation, which affects the functions of the cells and also increases the risk of DNA mutations that cause cancer. Excess body fat also increases the production of estrogen and insulin, which stimulates cancer growth.

 

• Stay active– Get regular exercises to prevent inflammation and maintain a healthy weight. You should exercise daily for 45 to 60 minutes and avoid sitting for a long time. Take short walks every hour during breaks.

 

• Eat healthily– A healthy diet consisting of plant-based foods can minimize your risk for cancer, sugary foods, processed foods, and processed meat can increase your risk. Your diet should contain whole grains, vegetables, fruits, and beans, which have antioxidants that can prevent body cells from damage.

 

• Drink alcohol in moderation– You can abstain from drinking alcohol or limit your consumption to reduce the risks of cancers such as esophageal, liver, colon breast, and head and neck cancers. You can have at most two drinks a day if you are a man and one drink only if you’re a woman.

 

• Avoid overexposure to sunlight– Don’t expose yourself to ultraviolet rays from the sun and indoor tanning beds. Ensure you spend less time in direct sunlight and use sunscreen every day.

 

Though small, these changes can lower your risk of cancer. All you need is to modify your lifestyle and improve your overall health.

 

 

 

 

 

 

Northtexascancercenteratwise.com

New Guidelines for Patients to Access Cancer Care during Covid-19

 

The Federal guidelines have allowed cancer patients to access care even with the ongoing coronavirus epidemic. Since the outbreak of Covid-19, cancer care teams and their patients have experienced difficulty in making choices about administering treatments, screening, and diagnostic care.

 

The guidelines provided earlier advised some care centers to postpone non-essential and elective procedures to allow medical professionals to focus on emergency and Covid-19 patients. The hospitals will remain open and provide treatments critical to patients and others who have no access to care from their local healthcare centers. Other cancer procedures, like cancer screening, will be rescheduled or postponed.

 

Patients have been faced with uncertainty following the directive since their scheduled procedures have had to be delayed.

 

New guidelines from the U.S. Center for Medicare and Medicaid Services are a welcome relief for cancer patients in some regions. Hospitals have been advised to ease some of the restrictions and allow patients to access non-emergency and non-Covid-19 procedures and care. These guidelines are intended to work hand in hand with other steps taken by the government to enable a phased-in reopening of certain businesses while ensuring a decrease in new COVID-19 cases.

 

Now cancer patients can continue to receive care whenever they need it, especially through telehealth services. Hospitals and medical staff will continue to provide clinical and surgical procedures and administer preventive services when necessary.

 

Hospitals will need to establish non-Covid care zones to screen their staff and patients regularly. They must have adequate personal protective equipment for their patients and medical staff. The social distancing guidelines should be enacted and enforced and have quarantine areas for those who test positive for COVID-19.

 

All public spaces, hospital equipment, and patient rooms should be thoroughly cleaned and disinfected. The guidelines also direct that hospitals should have an adequate supply of medication, equipment, and supplies.

 

These new protocols will help prevent infection and spread of Coronavirus in hospitals. By observing them, hospitals will ensure the safety of their patients and staff while continuing to offer adequate cancer care to those who need it.

 

Is it Safe to Get a Second Opinion about Cancer during this COVID-19 Pandemic?

 

Getting a second opinion about your cancer diagnosis is quite recommended. This will help you to confirm your diagnosis and get different ideas for your treatment, especially if your type of cancer is rare or hard to treat. But how safe is it to seek for a second opinion with the ongoing coronavirus pandemic?

 

If you’re wondering whether you should get another doctor’s opinion, you shouldn’t because you deserve to have your concerns addressed. Therefore, you should go ahead and get a second opinion.

 

Deciding What’s Right for You

 

A second opinion can help you make the best decision about your cancer treatment or management. It’ll also provide you with important insights into the ideal timeline for your treatment.

 

When another specialist reviews your case, they can confirm how quickly you should start your treatment or if it’s safe to wait until the coronavirus pandemic is controlled.

 

How Cancer Centers Are Handling Second Opinions in the Coronavirus Era

 

Most cancer centers have clinicians specialized in every type of cancer, and they’ll gladly consult with you and discuss the latest treatment options for your type of cancer. With the new guidelines in place, you’ll receive adequate care and attention safely through telehealth appointments. Whenever you need to visit the hospital, they have extra precautions in place that will protect you. You’ll wear your mask, get screened, and get tested for COVID-19 before your admission, surgery, or any other treatment.

 

A second opinion gives you confidence when making decisions regarding your cancer treatment. It makes you feel good, especially when you know that you are in control of your situation and any future decisions you may have. Even if you can’t control what happens with Coronavirus, you’ll still be able to take charge of your cancer diagnosis by getting another opinion that will help you plan your next course of action.

 

 

 

How to Cope with Fear of Recurrence after Breast Cancer Treatment

 

The fear of your breast cancer recurring after treatment can impact yours and your loved ones’ quality of life.

 

Breakthroughs in breast cancer screening, early diagnosis, and treatment have helped to increase patient survival rates across the world. But still, survivors continue to worry about their disease recurrence.

 

An interdisciplinary team of researchers has examined how the fear of breast cancer recurrence can affect the overall well-being and relationships between patients and their loved ones.

 

The research focuses on three health behaviors influenced by breast cancer recurrence fears and how they can also protect the patient from any future recurrence. The behaviors include quality sleep, physical activity, and taking of therapeutic hormonal medicines. The team is also going to study the sleep quality and physical activity of the patient’s spouse since they are also affected when their loved ones have cancer.

 

According to one of the researchers, the fear of recurrence is a major concern, and the most shared adverse psychosocial effect of breast cancer and its treatment. Patients have to live with physical symptoms as well as the fear of recurrence, which can persist for a long time.

 

When symptoms become chronic, they’ll interfere with the patient’s ability to engage in healthy behaviors that may protect them. This will also affect their ability to achieve their treatment goals and minimize their chances of recurrence. Therefore, the research team wants to understand what breast cancer patients and their partners experience from a couple’s perspective.

 

Preliminary data from other sources suggest that the fear of cancer recurrence is linked to sedentary behavior, weight gain, not adhering to the recommended medication regimens, and not getting enough sleep.

 

A study found out that patients who felt fear could not share it with their spouses. When they can’t process it with others, they can’t also think straight, so they’ll do unexplainable things.

 

There’s hope that the research will help doctors understand how the fear of recurrence can help develop interventions that will improve patients’ health behaviors and their spouses and boost their overall well-being.

 

Lewisvilleflowermoundoncology.com

How Cancer Treatments Destroy the Immune System

 

Cancer treatments can damage a patient’s immune system and cause conditions that may increase their risk of infection. Surgery, radiation therapy, chemotherapy, and other cancer drugs can be too much for the body to handle and cause adverse side effects. This compromises the immune system and affects its performance. It’s important to understand how cancer treatment may damage the immune system and take measures to protect yourself.

 

How Different Treatments Impact the Immune System

 

Cancer treatments help fight the disease in different ways, which affects the immune system differently. Chemotherapy drugs, for instance, are designed to kill cancer cells but may also destroy healthy cells in the bone marrow, which produce immune cells. This prevents their ability to protect you from bacteria, illnesses, and other threats.

 

A major surgery exposes the body to germs since it may also involve removing lymph nodes that help fight infection. The procedure can burden the immune system and exhaust all its reserves to help heal the wounds and prevent infection.

 

During radiation therapy, cancer cells are destroyed through exposure to ionizing waves of energy. The treatment also damages healthy cells leading to conditions that increase a patient’s risk of infection.

 

Immunotherapy drugs known as checkpoint inhibitors are meant to boost the immune system and help to identify and attack cancerous cells. However, this can cause the immune system to become overactive and attack healthy cells, causing flu-like symptoms or other serious autoimmune conditions like colitis.

 

CAR T-cell therapy includes using re-engineered immune cells to attack specific cells and treat certain types of lymphoma or leukemia. But the therapy can also exhaust or damage B-cells, affecting the body’s ability to produce antibodies.

 

During stem cell transplants, the patient is given intense radiation therapy and chemotherapy in order to prepare the body to receive new donor cells. Allogeneic transplants may cause a condition known as graft versus host disease if the recipient rejects the donor cells. This will result in recurrent infections and symptoms.

 

 

Self-Checking for Symptoms of Skin Cancer

 

The American Cancer Society estimates that about 1 in 5 Americans will develop skin cancer during their lifetime. Since this type of cancer is becoming very common, identifying and treating it early is the key.

 

It’s vital to evaluate the health of your skin from time to time. The Skin Cancer recommends doing this every month. One of the most critical measures to take in identifying skin cancer early is to frequently carry out a self-check in any areas of concern and see a dermatologist immediately.

 

When you understand your skin’s features such as freckles, moles, and blemishes, you’ll most likely notice changes in mole size or color and other markings on your skin that were not there before. When this happens, you should see your doctor as soon as possible.

 

Before self-checking your skin for symptoms of cancer, you should know what to exactly you are looking for.

 

To perform a successful skin cancer check, you’ll need bright light, a full-length mirror, a handheld mirror, a blow dryer, and a cell phone or notebook to keep a record of any new spots you may find.

 

Performing the Self-f-Check

 

Stand before the mirror and thoroughly check the front, back, right and left sides of your body for any age spots, freckles, or moles. You should also check your forearms by bending your arms at the elbow. The hand mirror will help you check the back of the neck, while the blow dryer will assist you in checking the scalp. Make sure you exhaust every part of your body, including your underarms, underneath the breasts, areas between your fingers and toes, the scalp, and bottoms of your feet.

 

What to Look For During a Skin Cancer Self-Examination

 

The best way to know what to look for is to use the ABCDE guide for melanoma to check for unusual spots. If you notice a birthmark, mole, beauty mark, or a pigmented spot on any part of your body, see your dermatologist right away. One half of the spot may not look like the other, or the spot’s color may not be consistent. The spots may also look different in both color, size, shape, or texture. If the spots are sore, itchy, painful, crusty, or bleeding, go to the doctor.

 

Getting a Mammography and Eating High Fiber Diet Can Help Fight Breast Cancer

 

Early screening can help detect and reduce the risk of developing breast cancer. New research has shown that going for mammography screening can significantly reduce the rate of advanced, fatal breast cancer.

 

In their findings, the research team observed that mammography screening reduces fatal breast cancer risk by 41% within 10 years of patient diagnosis and 25% reduction in advanced breast cancer rates.

 

Although recent breakthroughs in breast cancer treatment have improved outcomes, finding the disease early is still vital.

 

Researchers compared the rates of fatal breast cancer within 10 years after diagnosis for patients who had mammograms and those who didn’t. It was found that the average time of fatal breast cancer occurrence within 10 years of diagnosis was 13 years, and that of advanced disease was 22 years.

 

Overall, they found a 60% reduction of fatal breast cancer in 10 years of diagnosis among patients who underwent screening compared to those without testing. This goes to show that screening can reduce the risk of fatal breast cancer. Having mammography can help detect breast cancer early and save lives.

 

Another study highlighted the importance of consuming a high fiber diet to prevent breast cancer.

 

According to the team, women who consume a diet rich in fiber, including vegetables, fruits, and grains, can lower breast cancer risk. The data collected from patients who consumed fiber diet found an 8% reduction in the risk for breast cancer.

 

More observational studies also demonstrated that a high fiber diet was associated with a low risk of breast cancer. The results were consistent for soluble fiber and women with postmenopausal and premenopausal breast cancer.

 

It is crucial for women to undergo mammography screening and consume high fiber to minimize the risks of developing breast cancer. Early screening can help identify the disease while it’s treatable.

 

 

 

Lascolinascancercenter.com

Factors that Can Help Reduce the Risk for Cancer

 

You can reduce your chances of developing cancer by addressing certain risk factors. This is because cancer affects many people worldwide, and most of them are not aware of the cause and the preventive measures to take.

 

According to research, cancer may result from a single cell mutation that grows out of control. Other factors increase the risk, which, if well assessed and addressed, can lower your risk of developing cancer.

 

They include:

 

• Tobacco consumption– If you chew tobacco or smoke pipes and cigarettes, you are at high risk of developing cancer. Smoking not only causes lung cancer but increases the risk of pancreatic, esophageal, oral, throat, and bladder cancers. To reduce your risk, you should quit smoking and dipping.

 

• Obesity– If you are obese, your risk of developing cancer is high. Obesity triggers the production of hormones linked to elevated cancer risks, such as estrogen and insulin. You can reduce your weight by eating right.

 

• Genetics– Knowing the medical history of your family can help you understand whether you are at risk for cancer or not. Having a gene mutation in the family means you are at high risk of cancer, especially if your siblings or parents have had cancer before. You should go for counseling to assess and learn how to reduce your risk or get screened and treated early.

 

• Exposure to U.V. rays– If you spend a lot of time in the sun, you have to use sunscreen. Otherwise, exposing your skin to ultraviolet rays damages DNA in skin cells and cause cancer. Limit your exposure to sunlight or wear protective gear that covers your skin. Apply sunscreen to your body every day.

 

• Alcohol consumption– Experts recommend that you consume alcohol in moderation. Alcohol contains a chemical known as acetaldehyde, which damages DNA and prevents cells from repairing themselves. Heavy drinking can increase your risk of various cancers, including those of the gastrointestinal system and breast.

 

The factors above can help you steer clear of the risks for cancer and enjoy a healthy, cancer-free life.

Cancer Patients Should Beware of COVID-19 and G.I. Symptoms

 

Covid-19 is a respiratory illness that also causes digestive symptoms, which can complicate the health of cancer patients. A study conducted on COVID-19 patients discovered that they also experienced gastrointestinal (G.I.) symptoms such as diarrhea, vomiting, nausea, and much more.

 

Before, there were concerns that cancer patients, especially those with lung cancer, were more vulnerable to infection. But based on recent studies, there are new additional concerns that cancer patients should be aware of.

 

Patients with gastrointestinal cancer can experience severe symptoms like diarrhea and nausea. For cancer patients with G.I. symptoms, they have to see the doctor determine whether the symptoms are related to COVID-19 infection or cancer.

 

Cancer patients experience adverse side effects such as weight loss, vomiting, nausea, and digestive issues from treatments such as radiation therapy and chemotherapy. A GI doctor is always available to take care of such patients.

 

Now that G.I. symptoms are also common in Covid-19 patients, it’s imperative that patients receive care immediately, including adequate isolation to prevent transmission. Cancer patients should seek medical attention immediately they develop GI-related or respiratory symptoms.

 

G.I. cancer patients infected with COVID-19 are likely to experience loss of appetite, severe nausea, and diarrhea. They require early hospitalization to prevent kidney damage and dehydration.

 

Doctors recommend that cancer patients and their family members should take extra precautions if they think they’re exposed or suspect they have the virus. They should isolate themselves and observe hygienic measures set for Coronavirus such as washing hands, wearing masks, keeping social distance, and more. The relevant bodies such as The U.S. Center for Disease Control and Prevention has outlined guidelines on how to protect yourself and your loved ones during COVID-19.

 

As a cancer patient undergoing treatment or a survivor concerned about Covid-19 and its impact on your care, you should consult with your care team for more advice.

 

 

 

 

Symptoms for Colon Cancer That Are Often Overlooked

 

Colon cancer does not present symptoms in its initial stages. Screening is vital to finding and treating the disease early. If not detected early, colon cancer can advance, making it challenging to treat effectively.

 

Colon cancer begins as polyps in the lining of the colon. A colonoscopy can identify and remove these polyps before they turn cancerous. Treatment is often successful for early-stage colon cancers, and many patients can survive their disease at this time. It is recommended to start screening for colon cancer at age 50 for those at average risk and age 40-45 for those at high risk.

 

Recently, colon cancer has increased among young adults, which has made doctors assess every patient’s risk.

 

Sometimes colon cancer can present non-specific symptoms that can easily be overlooked. You need to pay attention to your body and get evaluated by a physician when you develop unexplained symptoms.

 

Here are a few symptoms that may indicate the presence of colon cancer;

 

• Blood in stool– Rectal bleeding can be caused by colon cancer, although this bleeding can be caused by something else. You may notice your stool has red blood, or it’s d that your stool is dark-colored.

 

• Abdominal discomfort or pain– Abdominal discomfort can be due to food intolerance from viruses and various other causes, including colorectal cancer. When abdominal pain becomes persistent, colon cancer cannot be ruled out. Seeking medical attention will help to evaluate your situation to determine the exact cause.

 

• Anemia– Anemia is another symptom of gastrointestinal bleeding. Anemia causes low blood cell count, which means there aren’t enough red blood cells to transport oxygen to the rest of the body. A blood test can be used to diagnose anemia by conducting a blood count and testing for hemoglobin. Anemia symptoms include feeling fatigued.

 

Since it doesn’t present symptoms early, colon cancer can be discovered late when it’s already become aggressive and metastatic. It’s essential to pay attention to any unusual discomfort or pain in your abdomen, blood in the stool, unexplained weight loss, diarrhea or constipation, and much more.

 

Southlakeoncology.com

The Connection between Colorectal Cancer and Blood Infections

 

According to new research, there’s a link between blood infections and colorectal cancer. The infections are caused by anaerobic bacteria in the blood. Certain blood infections increase your risk of developing colorectal cancer. The study is designed to help doctors to effectively screen patients for colorectal cancer.

 

Risk factors for colorectal cancer include age, genetic syndromes, family history of the disease, obesity, inactivity, and inflammatory bowel disease.

 

Anaerobic bacteria can function without oxygen. They are naturally found in various parts of the body, including the gut. These bacteria do not often cause infections, and when they do, it’s usually in the area inhabited by bacteria.

 

A previous study linked particular anaerobic bacteria with colorectal cancer but needed more research to explore the findings. This new research is being conducted to study the details and explore the connection further.

 

During the study, the team collected data on many different blood infections, including the types of pathogens they found in the participants’ bloodstreams.

 

Of all the participants who had a bacterial infection in the blood, 1.1% developed colorectal cancer later on, with 0.5% being within the first year of their infection.

 

They also discovered that anaerobic bacterial infections of the blood were linked to a significant increase in colorectal cancer risk.

 

Those found to have Clostridium septicum infection were highly likely to develop colorectal cancer within the coming year.

 

Only 0.5% of those with a bacterial infection developed colorectal cancer compared to 20.8% of the participants with a Clostridium septicum infection.

 

Overall, the team observed that people whose blood infections were caused by specific anaerobic bacteria had 42 times increase in the risk for colorectal cancer compared to those with aerobic bacteria such as staphylococcus aureus or Escherichia coli.

 

This discovery can help doctors to recommend screening for colorectal cancer in selected persons. However, more research is needed to help determine the causal relationship between colorectal cancer and blood infections.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Effects of Processed Meats on Cancer Risk

 

A lot of knowledge about cancer is available on the internet, but people still require elaborate answers on which foods can help reduce their risk. Some research projects have confirmed a few foods that may reduce your risk for cancer, while other foods have no evidence to back up their impact on cancer risk.

 

For example, sugar is perceived to feed cancer, but there isn’t any conclusive research that backs this up. Cancer cells indeed need sugar, among other nutrients, but almost every cell in the body needs glucose. If you stop consuming all the sources of natural sugars from vegetables, fruits, beans, grains, and milk, you’ll also starve the healthy cells in the body and become malnourished.

 

It’s recommended that you limit your refined sugar consumption by avoiding too many baked products, soda, candy, and instead stick to natural sources like fruits. For sweeteners, you can go for naturals such as honey, Truvia, and stevia instead of using artificial sweeteners.

 

On the other hand, processed meats have added preservatives that cause pancreatic cancer and other cancers. They are preserved through processes like salting, smoking, and other chemicals that help to prolong their shelf-life. When smoked, meats absorb tar due to an incomplete combustion process. These tars have carcinogens similar to those found in tobacco.

 

Although processed meat and other foods increase cancer risk, they have not been ruled by the FDA as too dangerous to eat. It is recommended that you limit your consumption to16 ounces of meat every week to reduce your risk of developing cancer.

 

Cooking your meat at very high temperatures in an open flame also produces heterocyclic amines and polycyclic aromatic hydrocarbons, which are carcinogens. Consuming these carcinogens can increase your risks for stomach cancer and colorectal cancer. Make sure you cook your meats at moderate temperatures.

 

 

 

 

 

 

 

 

 

FDA Approves Chemo-Free Combination Drugs for Lung Cancer

 

The FDA has approved a combination of drugs as first-line treatment for lung cancer. The combo includes ipilimumab (Yervoy, Bristol-Myers Squibb) and nivolumab (Opdivo, Bristol-Myers Squibb), which can treat patients with metastatic non-small cell lung cancer with tumors that express PD-LI (≥ 1%). The drugs are limited to lung cancer patients without the epidermal growth factor receptor or anaplastic lymphoma kinase genomic tumor aberrations.

 

A companion diagnostic device known as PD-L1 IHC 28-8 pharmDx was also approved by the FDA to help identify patients who are candidates for the combination treatment.

 

The FDA approval came after a randomized clinical trial was conducted in patients with recurrent or metastatic non-small cell lung cancer who had no prior anticancer treatment.

 

In the first stages of the trial, patients were assigned to receive a combination of nivolumab and ipilimumab or platinum-doublet chemotherapy. The median overall survival was found to be 17.1 months versus 14.9. The overall response rate was confirmed to be 36% and 30%.

 

The median response duration took 23.2 months for the group using nivolumab and ipilimumab, while the platinum-doublet-chemotherapy group took 6.2 months.

 

Patients on the nivolumab and ipilimumab showed adverse reactions including rash, fatigue, low appetite, diarrhea/colitis, musculoskeletal pain, pruritus, dyspnea, nausea, cough, and hepatitis.

 

The recommended dose for patients with metastatic non-small cell lung cancer is 3 mg/kg every two weeks for nivolumab and 1 mg/kg every six weeks for ipilimumab until the progression of the disease or if there’s unacceptable toxicity. The dose can also take up to 2 years for patients without disease progression.

 

Although the results of the study indicate there’s a new treatment option for metastatic non-small cell lung cancer, there’s a need for more research to point outpatients who can benefit from two immunotherapies, with a combination of immunotherapy and chemotherapy or with just one single agent.

 

 

 

 

 

 

Pet-ct-lascolinas.com

FDG-PET Can Accurately Predict Melanoma Relapse after Immunotherapy

 

Patients with total metabolic response on FDG-PET scan should get consideration with complete response. Those with a partial response on a C.T. scan and a complete metabolic response on FDG-PET scan should be considered to have achieved a low risk for melanoma relapse and complete response.

 

Patients with metastatic melanoma treated with anti-PD1 immune checkpoint inhibitors have experienced sustainable clinical activity. However, there’s the need to identify the strong predictive factors for relapse risk and long-term outcomes.

 

A study was conducted to compare FDG-PET imaging with C.T. scans to distinguish residual tumors and the absence of the tumor in metastatic melanoma patients treated with anti-PD1 immunotherapy. All patients considered to be in remission had FDG-PET imaging, and C.T. scans performed immediately after discontinuing immunotherapy treatment had clearly identified targets on the imaging scans.

 

The outcome of the first study was a relapse that occurred during follow-up. The CT imaging response was evaluated using criteria in solid tumors (RECIST): P.R., progressive disease (P.D.), complete response (C.R.), and stable disease (S.D.). The FDG-PET imaging was classified as a progressive metabolic disease, stable metabolic disease, CMR, and residual FDG avidity (RFA).

 

In CT imaging, 9 out of 26 patients in complete remission had a C.R., and 2 of them relapsed after 3 and 9 months; 15 of the participants had a P.R. and four relapses after 7, 13, and 14 months. Only two patients with an S.D. on C.T. scans did not relapse. There were no P.D.s either.

 

According to FDG-PET evaluations, 20 of the 26 patients in total remission had a CMR with only one relapsing after 9 months. Six participants had an RFA, with five of them relapsing after 3, 7, 13, and 14 months. None of the patients had a PMD or SMD.

 

There were discrepancies between PET and C.T. scans in 12 of the 26 patients. Ten of them showed a P.R. on the C.T. scan but a CMR on the FDG-PET scan, and none of them relapsed. The univariate analysis indicated that RFAs on FDG-PET scans were significantly linked to the occurrence of relapse. After making adjustments for age, sex, and RECIST score, FDG continued to be a good predictor of the relapse risk.

 

This model could help identify patients who are likely to respond to checkpoint inhibition in melanoma. The research team concluded that FDG-PET imaging can help predict long-term benefits of treatment and decision making regarding the discontinuation of treatment. More studies will be conducted to determine the stage of C.R.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Utilizing PET Imaging in Hodgkin Lymphoma

 

PET scans are frequently used in the medical community and oncology. Today PET imaging is used in combination with computerized axial tomography for more accurate results. PET has been adopted in the treatment of lymphomas, where it’s often incorporated in treatment for Hodgkin’s and non-Hodgkin’s lymphoma.

 

PET scans are used in staging and treating lymphomas that have the potential for a cure, such as large cell and aggressive lymphomas and classical Hodgkin’s lymphoma. They offer enhanced sensitivity and convenience and can detect disease in normal-sized lymph nodes to allow effective treatment.

 

PET scans have helped to change treatment approaches. Other conventional imaging processes have not been able to identify disease in bulky masses with some residual mass or scar, forcing them to be irradiated unnecessarily. But now PET scanning has engendered the rethinking of such approaches when there is no apparent disease activity.

 

Today, a negative PET scan after completing treatment is essential for a complete remission. Minimal relapses occur in small percentages. Data also shows that determining a response early after a few chemotherapy cycles can help predict the outcome for large cell lymphoma and classical Hodgkin’s lymphoma that data obtained at the end of the treatment. This has led to the initiation of clinical trials to find out if changing therapy early after on a PET scan will be beneficial.

 

Data indicates that a positive PET scan taken during or after chemotherapy can predict a high probability of failed treatment.  A positive PET scan can predict drug resistance.

 

During the early interim negative PET scan, treatment can be shortened by giving patients four to five cycles instead of the usual six.

 

The role of PET imaging in low-grade lymphoma is not very clear. The standard uptake value scores for low-grade lymphoma are low, whereas those for aggressive or large cell lymphoma are often higher. If a high standard uptake value in a node in low-grade lymphoma is found, it will prompt a biopsy to check for aggressive disease. This can help during the initial diagnosis when there may be multiple lymphoma pathology or later when there is suspicion of transformation.

 

 

 

 

Can CT Scans be used in Diagnosing COVID-19?

 

COVID-19 is often diagnosed through RT-PCR testing. Now some experts are arguing that C.T. scans can help to diagnose Covid-19. But others disagree with them.

 

The covid-19 epidemic continues to spread all over the world, killing many people as nations strive to find cure or vaccination. Diagnosing people with SARS-CoV-2 early is key to combating the spread of the disease. Once you are diagnosed, you can limit your physical contact with other people and slow down its spread.

 

To many people, reverse transcriptase polymerase chain reaction (RT-PCR) is the gold standard for Covid-19 diagnosis. RT-PCR is a molecular biology technique that identifies material specific to the SARS-CoV-2 virus. However, RT-PCR does not provide 100% accuracy, which has raised concerns about the false-negative and false-positive results.

 

So, is it possible that C.T. scans can serve as an adjunct to RT-PCR diagnosis? C.T. scans combine a series of images that reflect abnormal cells’ metabolic activity in the body.

 

Some reports claim that C.T. scans can be used in the diagnosis of COVID-19. C.T. scans help to effectively control the disease by detecting it early and monitoring and evaluating a patient’s progress. This will help in the rapid identification of the disease, tailored public health measures, and improved patient quarantining.

 

But other experts argue against using routine C.T. scans in diagnosing Covid-19 due to issues such as scanner contamination, false-positive rates, and lack of change in the individual management of the patients. Since RT-PCR testing is slow and unreliable, with low swab test sensitivity.

 

CT imaging, on the other hand, is more sensitive and can detect cases that are missed by swabs. It has a higher sensitivity and offers real-time results, although the issue of increased false positives can’t be ruled out. But this is not the greatest concern; high sensitivity is key to early detection, isolation, and stopping the human transmission of SARS-Cov-2. However, there’s also cause for concern regarding the risk of infection. People sharing the same scanner are at risk of getting infected.

 

Experts agree that RT-PCR should remain the gold standard for COVID-19 diagnosis, while C.T. scanning can be used only in complicated cases.

 

 

 

Txbreastcare.com

Mammography is Key to Reduced Risk for Fatal Breast Cancers

 

New data shows that regular screening with mammography reduces the rate of advanced and fatal breast cancers significantly.

 

The purpose of cancer screening is to identify tumors early when they are treatable. It helps to prevent the rise of advanced cancer cases associated with poor prognosis.

 

The data on mammography has been conflicting since some evidence suggests that screening can detect small, slow-growing tumors but will not prevent cancers diagnosed late.

 

In the new study findings,

 

There was a 41% reduced risk of patients dying from breast cancer in 10 years and a 25% decreased incidence of advanced breast cancer after undergoing screening. This just means that effective treatment is possible with early detection.

 

It confirms the findings of an earlier study that had evidence to prove that screening can reduce risks and incidences of fatal breast cancers. However, mammography screening only works by diagnosing breast cancer early to ensure treatment is successful, and recurrence with distant metastases and death does not occur.

 

Breast cancer can be less fatal when diagnosed at an early stage. In the study, the risk reduction benefit is attributed to mammography screening. The study findings support the laid guidelines for screening, and women can lower their risk of dying from breast cancer by adhering to the guidelines. The annual screening guidelines for women at average risk recommend that they should start screening at age 40.

 

This study now confirms that breast cancer mortality has improved because of treatment breakthroughs as well as early mammography screening. It also goes to show that treatment alone is not enough; screening can also help save more lives.

 

The mortality benefits for breast cancer are due to participation in routine mammography screening, independent of the new advances in treatment. This can help to reduce advanced and fatal stage breast cancers as well as a patient’s risk of dying from the disease. Overall, the large-scale study shows that mammography screening can bring long-term outcomes for breast cancer patients.

 

Strategy for Lowering the Risk for Fatal Breast Cancer

 

Women worried about developing fatal breast cancer have a solution that can possibly lower their risk.

 

The research was carried out to investigate how early mammogram screening can significantly reduce the risk of fatal and advanced breast cancer.

 

It was discovered that a large percentage of patients who underwent mammogram screening experienced a reduction in fatal cancers within 10 years after they were diagnosed with the disease. There was also a significant reduction in advanced breast cancer.

 

Although many women get routine mammogram screenings, others brush it off without knowing how beneficial screening is to their health and well-being. In the Centers for Disease Control and Prevention records, the percentage of patients over the age of 40 who took mammogram tests had increased to 65.3%.

 

The current study shows that finding breast cancer early is key to the survival of advanced and fatal breast cancer patients.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Immunotherapy Before Surgery Can Treat Patients with High-Risk Breast Cancer

 

A new study has discovered that women with high-risk HER2-negative breast cancer who’ve undergone immunotherapy before surgery and a PARP inhibitor with chemotherapy are highly likely to get rid of their cancer entirely from the lymph nodes and breast.

 

The results of the research provide additional evidence of the value of immunotherapy in treating early-stage breast cancer. It also suggests new avenues for utilizing immunotherapy drugs such as estrogen receptor-positive or HER3-negative breast cancer cases.

 

In some breast cancer patients, pre-surgical immunotherapy can destroy any evidence of cancer, helping to achieve pathologic complete response, which is a condition that improves the overall survival of the patients.

 

For women who have HER2-negative breast cancer and get treated before their surgery, their average pathologic complete response rate will significantly increase if they had an immunotherapy drug durvalumab and PARP inhibitor drug olaparib with chemotherapy compared to receiving chemotherapy alone.

 

As a checkpoint inhibitor immunotherapy, durvalumab is designed to stimulate the immune system T cells against cancer by inhibiting the PD-1. Olaparib impairs cancer cells to repair the DNA cells damaged by chemotherapy.

 

When the team analyzed the results for HER2-negative women and triple-negative and E.R. subsets, it was found that triple-negative patients who received combination treatment had a pathologic complete response rate of 47%. Estrogen-positive/HER2-negative breast cancer patients experienced a pathologic complete response rate of 28%.

 

In all subtypes, immune-rich cancers had high pathologic complete response rates. The team also discovered biomarkers that could single outpatients who would benefit from treatment with olaparib and durvalumab.

 

In HER2-negative/estrogen-positive cancers, the MammaPrint ultra-high subset was the one that benefited the most from this combination. In triple-negative breast cancer, the tumors with low CD3/CD8 ratio, high proliferation, and high Macrophage/Tcell-MHC class II ratio benefitted preferentially when durvalumab and olaparib was added to paclitaxel.